Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Alkermes plc (ALKS)

-NasdaqGS
44.94 Down 0.77(1.68%) 3:59PM EDT
|After Hours : 45.00 Up 0.06 (0.13%) 4:28PM EDT - Nasdaq Real Time Price
Prev Close:45.71
Open:45.19
Bid:44.83 x 100
Ask:45.97 x 100
1y Target Est:50.92
Beta:1.5
Next Earnings Date:31-Jul-14ALKS Earnings announcement
Day's Range:44.76 - 45.89
52wk Range:29.36 - 54.25
Volume:399,277
Avg Vol (3m):1,358,320
Market Cap:6.49B
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 1.68%6.49B
ABTUp 0.35%64.64B
LLYDown 0.92%68.42B
GSKDown 2.96%116.85B

Key Statistics

Forward P/E (1 yr):65.13
P/S (ttm):12.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.49
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):7.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback